
Alina Baum
Senior Staff Scientist , Regeneron Pharmaceuticals
The need to rapidly develop and commercialize therapeutics to fight COVID-19 has highlighted the importance of accelerating manufacturing development, and there are opportunities for the industry to carry forward the lessons learned from the pandemic into the future. Sessions will focus on Speed to Clinic, Speed to Launch, and End-to-End Supply Chain Resilience.